Skip to main content
logo
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.820
+0.040 (2.25%)
Aug 7, 2026, 3:04 PM EDT - Market open

Gain Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.060.140.16
Revenue Growth
----60.62%-15.08%471.29%
Gross Profit
---0.060.140.16
Operating Income
-19.69-18.71-20.35-22.25-17.78-13.83
Net Income
-21.24-20.16-20.41-22.27-17.59-13.89
Earnings Per Share
-0.58-0.61-0.89-1.71-1.48-1.37
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
16.5420.8410.3916.7920.1436.88
Total Debt
0.670.730.651.031.271.61
Net Cash (Debt)
15.8720.119.7315.7718.8635.27
Net Cash Growth
87.48%106.57%-38.27%-16.42%-46.52%466.03%
Net Cash Per Share
0.440.610.431.211.593.47

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-19.37-18.47-18.87-18.87-14.69-12.37
Capital Expenditures
---0.02-0.02-0.12-0.09
Free Cash Flow
-19.37-18.47-18.9-18.88-14.81-12.46
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----40328.30%-12688.10%-8379.80%
Pretax Margin
----40210.67%-12488.77%-8416.43%
Profit Margin
----40354.30%-12555.10%-8418.86%
FCF Margin
----34217.50%-10571.20%-7551.72%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---960.42265.47391.09